𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients

✍ Scribed by Angelo Zelante; Riccardo Borgoni; Cristiana Galuppi; Viviana Cifalà; Loredana Melchiorri; Sergio Gullini; Olavio Baricordi; Roberta Rizzo

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
154 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Different production of soluble HLA-G an
Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: A noninvasive diagnostic tool?
✍ Roberta Rizzo; Loredana Melchiorri; Loredana Simone; Marina Stignani; Andrea Mar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

Background: HLA-G antigens are nonclassical major histocompatibility complex (MHC) class I molecules characterized by tolerogenic and antiinflammatory properties. Recently, a different expression of HLA-G antigens has been observed between intestinal biopsies of ulcerative colitis (UC) and Crohn's d

Cytokine production in whole blood cell
Cytokine production in whole blood cell cultures of patients with crohn's disease and ulcerative colitis
✍ U. Elsässer-Beile; S. von Kleist; S. Gerlach; H. Gallati; J. Schulte Mönting 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 2 views

Levels of the cytokines interleukin-1 -a, -I$, and-2 (IL-1-a, IL-1-0, IL-2), tumornecrosis factor-cc (TNF-a), and interferon--/ (IFN-y) were measured in the mitogen-stimulated whole blood cell cultures from 96 patients with Crohn's disease (48 untreated, 12 treated with sulfasalazine, 36 treated wit

Diagnosis and management of dysplasia in
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon
✍ Thomas Ullman; Robert Odze; Francis A. Farraye 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

To minimize the possibility of developing lethal colorectal cancer (CRC) in ulcerative colitis (UC) and Crohn's colitis, patients are usually enrolled in a program of dysplasia surveillance. The success of a surveillance program depends on the identification of patients with dysplasia and timely ref